AMB.TO: Summary for AMBRILIA BIOPHARMA INC - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 4:18am EST - Canadian Markets open in 5 hours and 12 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

AMBRILIA BIOPHARMA INC (AMB.TO)

On Feb 9: 0.03 CAD 0.00 (0.00%)

MORE ON AMB.TO

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

AMBRILIA BIOPHARMA INC (Toronto:AMB.TO) Delayed quote data

Last Trade:	0.03 CAD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	0.03
Open:	0.03
Bid:	0.03
Ask:	0.035
1y Target Est:	N/A

Day's Range:	0.03 - 0.03
52wk Range:	0.03 - 0.40
Volume:	22,000
Avg Vol (3m):	45,968.8
Market Cap:	N/A
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add AMB.TO to Portfolio

Download Data

HEADLINES

•	Ambrilia Biopharma Provides Bi-Weekly Status Update
	Marketwire (Mon, Feb 8)

•	Ambrilia Biopharma Provides Bi-Weekly Status Update
	Marketwire (Mon, Jan 25)

•	Ambrilia Biopharma Provides Bi-Weekly Status Update
	Marketwire (Mon, Jan 11)

•	Ambrilia Biopharma Provides Bi-Weekly Status Update
	Marketwire (Tue, Dec 29)

•	Ambrilia Biopharma Provides Bi-Weekly Status Update and Announces Additional Cost-Cutting Actions and a Change to Its Board of Directors
	Marketwire (Mon, Dec 14)

•	Ambrilia Biopharma and ZBx Corporation Extend the Exclusive License Option Agreement for the Worldwide Rights to Ambrilia's PSP94 Technology for Prostate Cancer Diagnosis
	Marketwire (Mon, Nov 30)

•	Ambrilia Biopharma Provides Bi-Weekly Status Update
	Marketwire (Mon, Nov 30)

•	Ambrilia Biopharma Provides Bi-Weekly Status Update
	Marketwire (Mon, Nov 16)

•	Ambrilia Biopharma Obtains a Second Extension of CCAA Stay Order
	Marketwire (Fri, Oct 30)

•	Ambrilia Biopharma Provides Bi-Weekly Status Update
	Marketwire (Tue, Oct 20)

More Headlines for AMB.TO...

BUSINESS SUMMARY

No business summary available for AMB.TO.

Add to Portfolio

Email to a Friend

•